• Home
  • Bavana V. Rangan

Bavana V. Rangan

BDS, MPH
Program Director II, Center for Coronary Artery Disease
Bavana V. Rangan, BDS, MPH

Dr. Rangan joined the Minneapolis Heart Institute Foundation in October 2018 as program director for the Center for Coronary Artery Disease. In this role, she focuses on expanding and enabling the vision of the CCAD Science Center by developing MHIF’s investigator-initiated research portfolio and funding, and mentoring CCAD international scholars. She also serves as global director for the PROGRESS-CTO global multicenter registry on chronic total occlusions, a major initiative involving more than 50 participating centers and more than 7,000 CTO PCI procedures. As program director, Dr. Rangan also serves on the MHIF Blueprint leadership group dedicated to advancing MHIF’s growth and strategies.

Originally from Bangalore, India, Dr. Rangan received her dental degree from the Rajiv Gandhi University of Health Sciences, VS Dental College and Hospital. Drawn to a career in clinical research, she completed a Master of Public Health in clinical research at the University of North Texas Health Science Center School of Public Health. She subsequently built a strong background in clinical research in dentistry, rheumatology and cardiology, primarily within the VA North Texas Health Care System and the University of Texas Southwestern Medical School.

She began working with Dr. Emmanouil Brilakis in 2007 at UT Southwestern and the VA North Texas Health Care System in progressive roles, including director of research operations and faculty associate, and went on to serve as principal investigator on the LAVA registry and national coordinator on several trials, including the VA CSP #571 Drug-Eluting Stents in Saphenous Vein Graft Angioplasty (DIVA) trial, the CrossBoss FIRST trial and the ASAP-SVG trial, among other projects funded by the VA, NIH, industry and philanthropy. Dr. Rangan’s research expertise includes saphenous vein graft disease, chronic total occlusions, intravascular imaging and investigational drug and device trials.

Dr. Rangan has also served as a board member and reviewer on the VA North Texas Health Care System Institutional Review Board from 2012 to 2018 and received the VA’s Outstanding Cardiology Research Achievement Award in 2013. She is well published and is recognized as a leader in research administration and implementation.